A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19

5Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 2019 Coronavirus Disease (COVID-19) has become an unprecedented public crisis. We retrospectively investigated the clinical data of 197 COVID-19 patients and identified 88 patients as disease aggravation cases. Compared with patients without disease aggravation, the aggravation cases had more comorbidities, including hypertension (25.9%) and diabetes (20.8%), and presented with dyspnoea (23.4%), neutrophilia (31.5%), and lymphocytopenia (46.7%). These patients were more prone to develop organ damage in liver, kidney, and heart (P < 0.05). A multivariable regression analysis showed that advanced age, comorbidities, dyspnea, lymphopenia, and elevated levels of Fbg, CTnI, IL-6, and serum ferritin were significant predictors of disease aggravation. Further, we performed a Kaplan–Meier analysis to evaluate the prognosis of COVID-19 patients, which suggested that 64.9% of the patients had not experienced ICU transfers and survival from the hospital.

Cite

CITATION STYLE

APA

Tang, Q., Liu, Y., Fu, Y., Di, Z., Xu, K., Tang, B., … Di, M. (2021). A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87413-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free